Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets
Status:
COMPLETED
Trial end date:
2025-04-08
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetics of oxantel pamoate tablet after administration of a single and multiple dose in healthy male and female adult volunteers.
The main questions aim to answer if oxantel pamoate is safe and well tolerated in healthy volunteers and if is it absorbed by the human body.
A single dose and a multiple dose of oxantel pamoate will be compared to placebo to see if there are any different effects.
Phase:
PHASE1
Details
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborators:
Drugs for Neglected Diseases initiative Ifakara Health Institute